Skip to content

Capricor Therapeutics CAPR Payments To Acquire Leasehold Improvements

Payments To Acquire Leasehold Improvements at other companies

APA
Artisan Partners Asset Management Inc.APAM
$25K+92.3%
GATX logo
GATXGATX
$3.8M-74.7%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$0-100%
COPT Defense Properties logo
COPT Defense PropertiesCDP
$12.69M-12.4%
GATX logo
GATXGATX
$0-100%
LXP Industrial Trust logo
LXP Industrial TrustLXP
$11K-99.2%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$1.71B+303%
Enterprise value$1.62B+308%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept capr:PaymentsToAcquireLeaseholdImprovements.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's payments to acquire leasehold improvements.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's payments to acquire leasehold improvements?
Capricor Therapeutics (CAPR) reported payments to acquire leasehold improvements of $921.75K in Q1 2026.
How has Capricor Therapeutics's payments to acquire leasehold improvements changed year-over-year?
Capricor Therapeutics's payments to acquire leasehold improvements increased by 277.3% year-over-year, from $244.28K to $921.75K.
What does payments to acquire leasehold improvements mean?
This represents cash outflows dedicated to enhancing or modifying leased properties to suit the company's operational requirements. These capital expenditures are essential for building out laboratory or office space necessary for research and development. Tracking these payments helps assess the company's investment in its physical infrastructure.